Joseph M. Ortiz MD
Consultant in Ophthalmology, Abington Memorial Hospital, Abington, PennsylvaniaDr. Joseph Ortiz is a consultant in ophthalmology at Abington Memorial Hospital in Pennsylvania. He was formerly Associate Professor of Ophthalmology and Head of the Glaucoma Division and Associate Resident Program Director at Drexel University in Philadelphia. Previously, he held a similar position at Cooper Hospital – UMDNJ in Camden, New Jersey.
He is a diplomate of the American Board of Ophthalmology and a fellow of the American Board of Ophthalmology, the Royal College of Ophthalmologists (UK), and the College of Physicians of Philadelphia. He is a member of the American Glaucoma Society, the Association for Research in Vision and Ophthalmology, the American Association of Ophthalmic Oncologists and Pathologists, and the American Medical Association.
Dr. Joseph M. Ortiz earned his medical degree from New York Medical College, following which he did 1 year of anatomical pathology at Yale – New Haven Hospital, which was then followed by an NIH fellowship in ocular pathology at the Scheie Eye Institute – University of Pennsylvania, where he completed his residency in ophthalmology. This was followed by a glaucoma fellowship at Addenbrooke's Hospital in Cambridge, England. He completed a concurrent fellowship in ocular immune disease at Moorfields Eye Hospital in London.
Recent Contributions to PracticeUpdate:
- Efficacy of Selective Laser Trabeculoplasty for the Treatment of Patients With Glaucoma
- Progressive Changes in the Anterior Segment and Their Impact on the Anterior Chamber Angle in Patients With Primary Angle Closure Disease
- Outcomes of Partial vs Complete Goniotomy With or Without Phacoemulsification in Patients With Primary Open-Angle Glaucoma
- Association of Trabecular Meshwork Height With Steroid-Induced Ocular Hypertension
- Association Between Thyroid Eye Disease and Glaucoma
- Risk Factors for Surgery or Blindness in Eyes With Neovascular Glaucoma Treated With Anti-VEGF Injections by a Retina Specialist
- Success Rate of Glaucoma Drainage Device Revisions
- Morning Blood Pressure Surge and Glaucomatous VF Progression in Patients With Normal-Tension Glaucoma and Systemic Hypertension
- Rethinking Prophylactic Laser Peripheral Iridotomy in Primary Angle Closure Suspects
- Long-Term Risk of Steroid-Induced Ocular Hypertension or Glaucoma Associated With Topical Prednisolone Acetate 1% Use After DSEK